Patients taking Wegovy have nearly five times the risk of sudden sight loss compared with those on Ozempic, a large-scale study has found. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medicines such as semaglutide (sold as Wegovy, Ozempic and Rybelsus) and tirzepatide (sold as Mounjaro) help reduce blood sugar levels, slow digestion and reduce appetite, and … Read more
Online retailers and a Hong Kong pharmacy are offering slimming injections without prescriptions despite local authorities requiring a doctor’s approval before purchase, a Post investigation has found, with an expert warning it could lead to misuse. Weight-loss injections, which have been approved by Hong Kong authorities for use, have become increasingly popular around the world … Read more
Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Should Ozempic be added to the water supply? That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big… You can read the full story here: Ozempic: Should You Be Taking It?. Source … Read more
A new study published in the American Journal of Health-System Pharmacy suggests there may be a connection between a GLP-1 receptor agonist (GLP-1 RA) drug, semaglutide (sold under brand names Ozempic, Wegovy and Rybelsus) and an unusual side effect: painful skin sensitivity known as allodynia. The research focused on four patients who developed this symptom … Read more
A drug originally developed to treat diabetes, and now prescribed for weight loss, may have yet another significant application: stopping, perhaps even reversing, liver disease. In a phase 3 clinical trial involving 800 participants across 37 countries, and lasting 72 weeks, an international team of researchers found that a weekly dose of semaglutide was effective … Read more
Wegovy Gains preferred Status on CVS Caremark Formulary, impacting weight-loss drug market Table of Contents Wegovy Gains preferred Status on CVS Caremark Formulary, impacting weight-loss drug market wegovy gains preferred status on cvs caremark formulary,impacting weight-loss drug market key takeaways CAPITAL — May 2, 2025 — in a significant move within the weight-loss drug market, … Read more
Are you wondering if Mounjaro is effective for sustained weight loss? A recent three-year trial offers promising insights into the long-term effects of Mounjaro, revealing notable weight loss maintenance for participants. This article breaks down the key findings, providing a clear understanding of what the study reveals about Mounjaro’s potential in weight management. mounjaro Shows … Read more
We’re currently living through a moment in time when GLP-1 medications like Ozempic and Mounjaro are transforming our expectations about diabetes, weight loss and fitness. But there’s another large question looming overhead when it comes to these medications: can they sustain weight loss in the long term? While it isn’t quite an existential question for … Read more
Weight-loss jabs and those for diabetes may be linked to a lower risk of dementia, a study suggests. Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting the risk of conditions that impair memory and thought processes, according to researchers. Experts called for further research to shed light on how … Read more
Dementia’s links to diabetes, herpes explored as research widens South China Morning PostView Full coverage on Google News Source link